GENCYTE THERAPEUTICS INC
Logic-gated precision molecular adaptor (PMA) CAR-T cell immunotherapy system for JMML treatment
- Sector
- Biotech
- Headquarters
- SAN JOSE, CA
- Total capital
- $1.2M
- Federal grants
- $355K
- 1 award
- Rank in peer group#403 of 502
- Private capital raised
- None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
- Federal contracts
- $855K
- 2 awards · Health and Human S
- Rank in Biotech#195 of 4373
- Granted patents
- 0
- 4 pending
Capital timeline
Latest events
- Federal contractHealth and Human S · Phase I SBIR Concept Award For Logic Gated Molecular Adaptor System For Jmml Treatment$500K
- Federal contractHealth and Human S · Gencyte Therapeutics, Inc. Proposes Developing A Synthetic Notch Receptor (synnotch) Controlled Precision Molecular Adaptor (pma) System, Nameded Synnotch Pma Car, For Jmml Treatment. This Proposed Platform Technology Could Potentially Lower Car-t To$355K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
1 record has no date or no amount, so it isn’t placed on the timeline.
Standing among 502 peers
Line = medianBiotech · Molecule
- Federal grantsBelow median
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
No founders are linked to this company yet.
Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.
Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026
Claim this profile to add your teamWhat it has protected
USPTO · 0 granted of 4- PendingPrecision Molecular Adaptor System For Car-t ImmunotherapyUSPTOApplication 18504680
- PendingPrecision Molecular Adaptor System For Car-t ImmunotherapyUSPTOApplication 16958915
- PendingPrecision Molecular Adaptor System For Car-t ImmunotherapyUSPTOApplication PCTUS2019012468
Show all 4 patent records
- Precision Molecular Adaptor System For Car-t ImmunotherapyAug 1, 2024 · Application 18504680Pending
- Precision Molecular Adaptor System For Car-t ImmunotherapyOct 29, 2020 · Application 16958915Pending
- Precision Molecular Adaptor System For Car-t ImmunotherapyApplication PCTUS2019012468Pending
- Precision Molecular Adaptor System For Car-t ImmunotherapyApplication 62643077Pending
Related companies, and why
- PAK BIOSOLUTIONS, INC.Similar federal contract value in Biotech · $942K in contracts
- IREPROGRAM, LLCSimilar federal contract value in Biotech · $903K in contracts
- MEDIOMICS, LLCSimilar federal contract value in Biotech · $887K in contracts
- NOMOCAN PHARMACEUTICALS LLCSimilar federal contract value in Biotech · $854K in contracts
- Nanoscience Solutions, LLCSimilar federal contract value in Biotech · $849K in contracts
- INTRA-CELLULAR THERAPIES, INC.Similar federal contract value in Biotech · $849K in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .